Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
Mark Crowther, University Professor and Chair, Department of Medicine at McMaster University, Fellow at Canadian Academy of Health Sciences, shared American Society of Hematology’s post on LinkedIn:
“Congratulations to the authors on this important work – Pediatric thrombosis has been generally overlooked despite it being a cause of significant morbidity that can last for years.
Great work by the American Society of Hematology on building its stable of Guideline initiatives.”
American Society of Hematology shared a post on LinkedIn:
“ASH and ISTH have released new clinical practice guidelines on anticoagulant prophylaxis for pediatric patients at risk of VTE, offering long-awaited, evidence-based recommendations to support care for some of the most vulnerable children.
With VTE on the rise in pediatric populations, these guidelines provide critical clarity for clinicians and highlight areas where more research is needed.
Explore the recommendations and resources in the press release.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials